Marc Blaustein - Feb 21, 2023 Form 4 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role: Chief Operating Officer
Signature: /s/ Sydney Gaylin, Attorney in Fact
Stock symbol: FNCH
Transactions as of: Feb 21, 2023
Transactions value $: -$1,755
Form type: 4
Date filed: 2/23/2023, 03:05 PM
Previous filing: Oct 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FNCH	Common Stock	Sale	-$1.76K	-4.62K	-14.16%	$0.38	28K	Feb 21, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2	Represents the weighted average price of shares sold by the broker on behalf of certain employees of the company on February 21, 2023. The broker sold, in the aggregate on behalf of such employees, 21,651 shares in transactions ranging from $0.36 to $0.39 with a weighted average price of $0.38. The proceeds of all such sales were allocated to applicable employees on a pro rata basis based on the number of shares sold by such person. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Represents the weighted average price of shares sold by the broker on behalf of certain employees of the company on February 21, 2023. The broker sold, in the aggregate on behalf of such employees, 21,651 shares in transactions ranging from $0.36 to $0.39 with a weighted average price of $0.38. The proceeds of all such sales were allocated to applicable employees on a pro rata basis based on the number of shares sold by such person. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.